Food and Drug Administration (FDA) as a therapeutic agent, alongside issues of cost, accessibility, and long-term adherence, may limit its broader clinical integration
Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S
Numerous investigational therapies targeting inflammation, oxidative stress, liver regeneration, bile acid signalling, epigenetic regulation, and the gut-liver axis have been evaluated, with largely disappointing results
Connecting InsideTracker The science on citrulline malate is now robust enough that InsideTracker recommends citrulline malate for active individuals focusing on improving their strength and performance
Among patients with a diagnosis of PCOS, how many were prescribed semaglutide or tirzepatide